Committees & Departments

Directorate and Board of Governors

Directorate

Directorate

Prof. Dr. Jürg Utzinger

Director

Prof. Dr. Kaspar Wyss

Deputy Director

Additional Members of the Managing Board

Prof. Dr. Julia Bohlius Prof. Dr. Sébastien Gagneux Prof. Dr. Daniel Paris

Prof. Dr. Nicole ProbstHensch

Mathias Kronig

Board of Governors

Dr. Andreas Burckhardt

Chairman of the Board of Governors, Bâloise Holding AG (until April 2021)

Dr. Rolf Borner

Director Infrastructure & Operations, University of Basel

Dr. Ariane Bürgin

Head of Higher Education, Cantonal Department of Education, Basel

Prof. Dr. François Chappuis

Head of Tropical and Humanitarian Medicine Division, Geneva University Hospitals

Prof. Dr. Sabina De Geest

Director, Institute of Nursing Science, University of Basel

Dr. Doris Fellenstein Wirth

Head of the Department for Vocational, Secondary and Higher Education, Basel-Landschaft (deceased: 12.02.22)

Dr. Eva Herzog

Member of the Council of States, Canton Basel-Stadt

Dr. Olivier Küttel

Head, International Affairs, EPFL, Lausanne

Dr. Cornelia Staehelin

Senior Physician, University Hospital Bern

Dr. Benedikt Knüsel

Observer, Scientific Advisor at State Secretariat for Education, Research and Innovation, Bern

Prof. Dr. Jürg Utzinger

Director, Swiss TPH, (ex officio)

Mathias Kronig

Administrative Director, Swiss TPH, (ex officio) R. Geigy Foundation: Foundation Board and Administration

Prof. Dr. Marcel Tanner

President of Foundation Board, Director Emeritus, Swiss TPH

Beat Berger

Foundation Board Member, Managing Director, Berger Liegenschaften

Prof. Dr. Christoph B. Bühler

Vice-President of Foundation Board, Lawyer, LL.M., Honorary Professor at University of Zurich

Dr. Lukas Meier

Managing Director

Stefan Mörgeli

Foundation Board Member, Administrative Director Emeritus, Swiss TPH

Bernadette Peterhans

Foundation Board Member, Head of Professional Postgraduate Training, Swiss TPH (until 31 December 2021)

Nicole Probst-Hensch

Foundation Board Member, Head Department of Epidemiology and Public Health (as of 1 January 2022)

Jürg Toffol

Foundation Board Member, Architect, ETH SIA

Prof. Dr. Jürg Utzinger

Foundation Board Member, Director, Swiss TPH

Medical Parasitology and Infection Biology

The Department of Medical Parasitology and Infection Biology (MPI) investigates the biology and transmission of pathogens. Findings from this research inform the development of new diagnostics drugs, and vaccines against malaria, parasitic worm infections, Buruli ulcer, tuberculosis and Chagas’ disease.

Research on pathogen biology, hostpathogen interactions and immunity Researchers at MPI investigate the molecular and cellular mechanisms underlying pathogen reproduction and transmission. They use various infection models and clinical studies to investigate the host immune responses to infection as well as the molecules and processes influencing the course of disease.

Research on pathogen development and transmission Researchers study how these pathogens undermine host immunity and develop drug resistance, and how these phenomena influence transmission. They analyse the dynamics of infection, the biological changes linked to pathogen life cycles, and the effects of interventions such as vaccinations and therapies on the host microbiome and on the population structure of these pathogens.

Development of drugs, vaccines and diagnostics Researchers also develop novel infection models to evaluate new interventions. They use their knowledge of host and pathogen to test new diagnostics, drugs and vaccines in preclinical and clinical studies. Highlights in 2021 MPI continues to be excellent on all fronts. Till Voss’s unit generated new insights into the essential signaling pathways of Plasmodium falciparum, the main cause of human malaria. Findings from this work point towards novel drug targets and were published in PLoS Biology.

Claudia Daubenberger’s unit participated in a large collaborative effort to track the spread of SARS-CoV-2 across Africa. This work published in Science highlights the importance of global surveillance of emerging pathogens using large-scale genome sequencing.

Pascal Mäser’s unit was instrumental, together with several partners, in the development of a novel compound that bears potential as a new treatment for leishmaniasis (published in Angewandte Chemie International Edition).

Damien Portevin’s group developed a model system to study tuberculosis infection, which recapitulates important features of the disease and can be used to evaluate novel treatments (Frontiers in Immunology). Sébastien Gagneux, Head of MPI

Sébastien Gagneux and his team, together with partners in the country of Georgia, highlighted prisons as an important factor driving the evolution of multidrug-resistant tuberculosis (Nature Medicine).

In a large phase 3 clinical trial, Jennifer Keiser’s group together with our partners from Côte d’Ivoire, Lao PDR and Tanzania, demonstrated the superior efficacy of a new combination treatment against infection by the parasitic worm Trichuris trichiura. This work was published in The Lancet Infectious Diseases.

MPI also continues to be successful in acquiring new research grants. In particular, Jennifer Keiser acquired an ERC Advanced Grant from the European Research Council to continue her work on developing and understanding of new treatments against helminth infections.

Strategic areas & promotions MPI is further strengthening its research portfolio in basic infection biology. Specifically, Tiffany Bouchery has successfully started as head of the new group Hookworm Immuno-Biology and the work by Nicolas Brancucci and team on malaria-host interactions is now well on track. Sébastien Gagneux was promoted to Full Professor of Infection Biology at the University of Basel.

Epidemiology and Public Health

The Department of Epidemiology and Public Health (EPH) investigates the distribution and drivers of infections and non-communicable diseases. To understand and promote the well-being of people in different cultural and environmental contexts, EPH applies methods ranging from anthropology and social science to biostatistics and mathematical modelling as well as observational cohorts with biobanks.

In 2021, EPH had a total of 101 projects, which generated CHF 19.8 million in new funding. With over 100 employees and 130 PhD students, EPH is the largest department at Swiss TPH with 10 unique research units.

COVID–19, malaria and neglected tropical diseases EPH representatives participated in the Swiss national COVID– 19 science taskforce and conducted predictive modelling to investigate the impact of COVID– 19. Improved models were regularly added to the open source OpenMalaria platform for the simulation of malaria dynamics and control.

EPH continued to support the National Malaria Control Programme in Tanzania in vector control, case management and monitoring and evaluation and supports the malaria control programme in Zanzibar.

EPH supported the national Malaria Indicator Survey in Papua New Guinea and Angola to investigate the quality of malaria case management. Based on findings from the CARAMAL project, the WHO cautioned countries to scale up rectal artesunate only if health system strengthening measures can ensure an effective continuum of care. EPH continues to conduct research and interventions in the area of schistosomiasis. For example, EPH demonstrated a dramatically high prevalence of the infection in the Democratic Republic of the Congo (DRC). EPH participated in the Lao PDR national health survey and will develop the first Lao PDR national liver fluke infection risk map as a basis for future control activities. The new vector control research facilities in Allschwil and the vector control product testing in Tanzania will excel the development of new vector control tools.

In Switzerland, researchers run a large network of mosquito traps to monitor and control the spread of the invasive Asian tiger mosquito. This knowledge is now feeding into Aedes vector control in sub-Saharan Africa.

In Ethiopia, the brucellosis sero-survey in livestock and pastoralists was finalised and the results of the spread of brucellosis in pastoralists was documented and shared with the National Brucellosis Task Force. In Côte d’Ivoire and Mali, EPH also works towards zero human rabies deaths by applying blockchain technology.

Cohorts and biobanks Comparative cohorts and biobanks in Switzerland and on different continents are a central pillar of EPH. The COVCO-Basel cohort investigates the long-term societal impact of the COVID– 19 pandemic with more than 10,000 participants and documents the social inequity of the pandemic consequences in Switzerland. This study was extended to low- and middle-income countries, where EPH documented a compelling impact on the decrease of living standards and inadequate eldercare.

The 5-year follow-up of the SOPHYA cohort provides first time policy-relevant Swiss-wide data on physical activity and its individual, social and environmental determinants in children and adolescents. SOPHYA and COVCOBasel, together with the existing SAPALDIA cohort and the administrative Swiss National Cohort, formed the basis for non-communicable diseases and environmental and exposome science across the life course.

In the EPOCHAL and POCHAS projects, airborne pollen models were developed for health studies and proved that climate change impacts the pollen season. EPH hosted the ISEE Young 2021 virtual conference and its expertise led to the Framework Partnership Agreement for the European Topic Centre on Human Health and the Environment.

The results of the multigenerational Peruvian ALTO birth cohort suggested that living in high altitudes may increase the risk of metabolic syndrome. A parallel mother-child cohort is being implemented in Lao PDR and will integrate research on breastfeeding and children’s gut microbiome. The SwissLEGIO cohort conducted research on the individual, behavioural, environmental and infrastructural causes of the 5-fold increase of legionellosis in Switzerland over the past 10 years. Nicole ProbstHensch, Head of EPH

Taking science to impact The HIA4SD project was completed and is expected to strengthen the application of impact assessment as a regulatory mechanism to engage natural resource extraction projects. The Hands4Health project examined the health and well-being effect of novel interventions to improve access to hygiene and safe water, and is being tested in primary health care facilities and schools in Burkina Faso, Mali, Nigeria and Palestine.

EPH is also investigating the impact of health insurance on the livelihoods of cocoa farmers in Côte d’Ivoire. Swiss TPH also contributed chemical biomonitoring citizen data to the European-wide project HBM4EU.

Organizational changes and promotions As of 1 January 2021, a new unit called Vector Biology was formed with the merging of the New Vector Control Interventions, led by Sarah Moore and the Vector Control Group, led by Pie Müller. Congratulations to Jan Hattendorf who habilitated at the University of Basel, and Fabrizio Tediosi who has been promoted to Titular Professor at the University of Basel.

Swiss Centre for International Health

The Swiss Centre for International Health (SCIH) provides policy advice, project design and management services across the fields of public and global health. Hosting diverse, multi-disciplinary and multi-lingual teams in Switzerland and around the world, SCIH offers a broad range of technical and methodological expertise, including strategic consulting, project implementation, organisational assessments, evidence-synthesis, implementation research and economic evaluations. Kaspar Wyss, Head of SCIH

SCIH supports health systems development with a focus on Africa, the Balkans and Eastern Europe. Key areas include Primary Health Care (PHC) development, health workforce strengthening, health financing, health information systems, programme performance monitoring, supply chain management and digitalization. SCIH also covers women, children and adolescent health, nutrition as well as both non-communicable and infectious diseases of poverty. With over 60 collaborators in Basel and 180 abroad, SCIH staff work with partners to respond to local needs, thus tailoring the services to unique contexts and systems.

A large number of individuals in countries such as Cameroon, Chad, Nigeria, Rwanda, Somalia, Tanzania, Albania, Kosovo and Moldova, amongst others, benefit from improved quality of care, increased health service coverage and community engagement and ultimately better health. In all aspects of our work, we strive towards the achievement of the Sustainable Development Goals and progress towards Universal Health Coverage (UHC).

Highlights in 2021 and responses to the COVID–19 pandemic SCIH re-allocated funds and mobilised expertise to support national responses to the COVID– 19 crisis in many countries. In Rwanda, SCIH has improved the capacity of community health workers to handle the prevention of COVID– 19 through support from the Swiss Agency for Development and Cooperation (SDC). In Côte d’Ivoire and Nepal, SCIH supported the deployment of a Surveillance, Outbreak Response Management and Analysis System (SORMAS), a computerized epidemic surveillance system, through the EU-funded CORESMA project.

SCIH continues to operate as a trusted partner and implementing agency in long-term mandates for the Swiss and German governments. A new co-financed mandate focuses on Nutrition in City Ecosystems (NICE), connecting the demand and supply side of food systems and engaging women and youth in two secondary cities each in Bangladesh, Kenya and Rwanda. SCIH also began a second project in Kosovo establishing qualitative, affordable and integrated care to patients with non-communicable diseases. This and several similar longterm projects have allowed the strengthening of primary and secondary health care services, as well as quality improvements respectively improving the financial, cultural and geographical accessibility of health services for the population.

SCIH provides services to develop and implement health financing strategies and assess the economic viability of health system interventions. In Chad, SCIH analysed a non-contributory insurance scheme for economically vulnerable people on behalf of the Gesellschaft für Internationale Zusammenarbeit (GIZ). In addition, SCIH is working with the Revolutionary Government of Zanzibar to establish key building blocks for the UHC reform process.

Electronic Clinical Decision Support Systems (CDSS) can guide health workers in appropriate and evidence-based patient evaluation and management. Several projects implemented by SCIH are based on CDSS methods and technologies and are making important contributions to improving the quality of clinical care such as through a more rational use of antibiotics. Examples include the childcare enhancement projects for the International Committee of the Red Cross (ICRC) in Nigeria and Somalia (ALMANACH), a project to improve healthcare in refugee camps in Chad (SysRef) and an innovative approach to infant care in Tanzania and Rwanda (DYNAMIC).

Services to the Global Fund and Gavi SCIH continues to provide Local Fund Agent (LFA) services to the Global Fund and monitors programme implementation relating to HIV/AIDS, tuberculosis and malaria control/ elimination and health systems strengthening for 14 portfolios mainly in francophone Africa and the Middle East region. Swiss TPH has been reviewing revised detailed budgets and protocols, relevance and effectiveness of savings identified by countries, as well as detailing assumptions of COVID– 19 related activities, best value for money investments, and conducted short local surveys on quality and price of protective equipment.

In the frame of the COVAX Facility, the global initiative for pooled procurement and equitable distribution of COVID– 19 vaccines, we have been appointed by Gavi, the Vaccine Alliance, as monitoring agent to oversee the rollout of the vaccines in Cameroon, Benin, Mali and Chad. We also continued to implement on behalf of Gavi, a Programme Audit mandate relating to Chad and Burkina Faso tracking the implementation of vaccination activities as well as Monitoring Agent mandates in Burundi and Côte d’Ivoire. A Monitoring Agent mandate in South Sudan has been completed in view of optimising vaccination coverage.

Medicine

The Department of Medicine (MED) provides unique services in tropical and travel medicine and performs clinical research relating to drugs, diagnostics and vaccines with a focus on tropical and poverty-related diseases. The major pillars are the Swiss Centre of Excellence for Tropical and Travel Medicine, the National Diagnostic Reference Centre for Imported Parasitic Diseases and an expanding Center for Clinical Translational Research involving academia and industry related projects.

The year at a glance In 2021, MED recuperated gradually from the impact of the COVID–19 pandemic. Clinical medical and diagnostic service activities increased with the lifting of pandemic-associated travel restrictions. The Diagnostic Centre improved its turnover with the acquisition of new projects, while the Clinical Operations unit maintained its services at international study sites and acquired new projects in COVID–19. All clinical research activities continued despite the restrictions and thanks to the integrated activities with our partners abroad.

Teaching and training activities in MED continued unchanged throughout the year. The lectures and courses were held in online formats and towards the end of the year more in-person courses resumed.

Regulatory compliance efforts The ongoing efforts in developing capacity for sponsorship in international clinical trials became more visible, with three active projects with Swiss TPH as sponsor. The partnership with the Department of Clinical Research of the University of Basel led to a synergistic collaboration allowing MED to provide medical monitoring, pharmacovigilance and validate electronic data capture solutions. MED also implemented a validated clinical trial management system.

With these steps, MED came closer to the goal to be an interesting partner and preferred provider for academic and industry-related R&D projects, by providing a comprehensive package of relevant clinical trial support functions, including site evaluation, project management, monitoring, GCP training and data management.

Notable research highlights As part of a collaboration between teams in Lesotho and Zambia, Klaus Reither, Head of the Clinical Research unit, and team obtained a grant from the Botnar Research Centre for Child Health (BRCCH) and the European and Developing Countries Clinical Trials Partnership (EDCTP) to investigate the effects of community-led interventions, rapid point-ofcare diagnostics and swab self-collection in mitigating the COVID–19 epidemic. The International HIV and Chronic Disease Care group was successful in completing and publishing several studies, including the VIBRA trial, a cluster-randomized trial assessing lay-provider initiated antiretroviral therapy after homebased HIV testing.

In collaboration with SolidarMed, ComBaCaL began, which is a five-year project funded by the Swiss Agency for Development and Cooperation (SDC) to tackle non-communicable diseases in rural Lesotho. Jennifer Belus was awarded with the prestigious SNSF Ambizione fellowship grant to address the mental health treatment gap in sub-Saharan Africa.

The Swiss TPH-led DAVINCI consortium funded by the Botnar Research Centre for Child Health (BRCCH) developed a highly sensitive saliva-based rapid diagnostic test for COVID–19; the prototype is currently under clinical evaluation. The NIIDS project funded by the Stanley Thomas Johnson Foundation addressing the health care requirements and developing diagnostics for migrants and refugees in Ethiopia unfortunately experienced a major set-back due to the rising conflict in Ethiopia.

The Medicines Implementation Research unit, in collaboration with the Health Intervention unit at EPH, completed the CARAMAL project, assessing the impact of quality controlled rectal artesunate (RAS) as an intervention for children with malaria on their referral pathway. The study conducted in the Democratic Republic of the Congo, Nigeria and Uganda in over 13,000 children, revealed severe health system weaknesses and demonstrated that it is not sufficient to distribute RAS without addressing these challenges and deficiencies along the continuum of care.

Diagnostic development and services for research The new laboratory information system in routine diagnostics has greatly improved the Daniel Paris, Head of MED

processes and electronic transfer of medical reports to hospitals and laboratories. The diagnostic team contributed with SARS-CoV–2 testing in Switzerland.

The Diagnostic Centre also supports clinical studies of external partners by providing services for quality control, genotyping and assay development. Multiple trainings in malaria diagnostics and proficiency testing were performed with external laboratories abroad for industry clients.

Clinical operations The Clinical Operations unit had a breakthrough with Médecins Sans Frontières (MSF) in the TB PRACTECAL clinical trial, which revealed that a new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis than the current standard treatment. Further, the study teams provided recruitment in the CALINA trial, a Novartis study to evaluate the first malaria treatment for neonates and infants weighing less than 5 kilograms.

Personal highlights We congratulate Esther Künzli on her habilitation at the University of Basel and also to her new position as co-lead of the Medical Services, together with Andreas Neumayr.

Education and Training

The Department of Education and Training (ET) coordinates classes and programmes at Swiss TPH, the University of Basel and academic institutes around the world. In the midst of the COVID-19 pandemic, Swiss TPH mastered a fast, lean and successful switch from physical to virtual teaching and training in close collaboration with other departments at Swiss TPH and in regular exchange with University partners.

The 120 teachers who train bachelor, master, doctoral and postgraduate students went through a steep learning curve in digital education and training, but have since mastered online and hybrid learning and continue to take it forward with remarkable ease.

Throughout the year, Swiss TPH faculty supervised around 250 MSc, MD, PhD and postgraduate MAS theses, and 620 participants were trained in postgraduate courses. The library was temporarily closed due to the pandemic, but a pickup service for books was offered and other library services continued as usual. In early 2022, Education and Training began its courses at Swiss TPH’s new headquarters in Allschwil, just outside of Basel.

Highlights in 2021 In the spring of 2021, the 27th edition of the Health Care and Management (HCM) course began virtually. 16 participants from 12 different countries participated virtually from around the globe due to the COVID– 19 pandemic. As of April 2022, two thirds of the course participants were able to travel again and attend in person and thus a hybrid model was initiated. There was need for agility, collaboration and dedication for mutual learning from both the online and on-campus participants and facilitators to make the course possible in these challenging times. All 16 participants successfully graduated with the Diploma of Advanced Studies in Health Care and Management. Special thanks to all those who contributed to the success of the course, and the Basel City Stipend commission and the R. Geigy Foundation for supporting 10 course participants.

The virtual Lugano Summer School in Public Health Policy, Economics and Management, jointly organised by SSPH+, Università della Svizzera italiana (USI), Scuola universitaria professionale della Svizzera italiana (SUPSI), and Swiss TPH, and supported by the fellowship programme of the Swiss Agency for Development and Cooperation (SDC), was another highlight. With 14 courses visited by 174 students – including 59 SDC fellowship students – and 10 plenary sessions open to students, alumni and the public, the Lugano Summer School attracted students from 45 countries.

In the fall of 2021, the 77th edition of the eight week CAS course “Internationale Zusammenarbeit und Globale Gesundheit” was held with 41 participants. The course, which was Julia Bohlius, Head of ET

previously known as “Allgemeiner Tropenkurs”, has been offered at Swiss TPH since 1944.

Strategic areas Online teaching and training was strengthened as part of the aim to lower Swiss TPH’s carbon footprint. The pandemic strengthened and grew the global community of teachers, facilitators and students, and they mastered digital learning and teaching. Physical learning and teaching opportunities were proactively embraced without hesitation whenever possible.

Further progress was made in the development and coordination of the interfaculty Graduate School Health Sciences (GSHS) of the University of Basel. The aim of the graduate school is to unite around 350 PhD students of health sciences – including over 170 from Swiss TPH – under the umbrella of four PhD programmes and a joint platform of courses and events.

Swiss TPH’s lively national and international partnerships in teaching and training, including with the SSPH+ network across 12 Swiss universities, has actively continued. Lao Tropical and Public Health Institute in Lao PDR, Cayetano University in Peru and the Ifakara Health Institute in Tanzania are several examples.

Organisational changes In May 2021, Karin Gross took over as Head of the Professional Postgraduate Training unit of the Department of Education and Training from Bernadette Peterhans, who retired after 27 years of commitment to Swiss TPH, students and facilitators around the world. The transition went smoothly and Bernadette Peterhans will continue to teach selected topics. Julia Bohlius was promoted to Titulary Professor in Cancer Epidemiology at the University of Basel. Given the upcoming retirements of two out of the four unit heads, ET is currently preparing for further transitions.

Administration

Administration supports research, education and services as well as the staff at Swiss TPH with the following units: Finances and Controlling, Human Resources, Informatics and Infrastructure. In total, about 70 employees work in Administration at Swiss TPH.

Over the past four years, Administration has been involved in the entire process of project and utilization planning for Swiss TPH’s new headquarters “Belo Horizonte”. Belo Horizonte is the largest project in the history of Swiss TPH. In 2021, the focus was on the relocation and commissioning of the new building. Administration was responsible for the preparation and implementation of the move as well as the preparation of the employees for the new working environment.

Despite the COVID– 19 pandemic, the project was completed on schedule. The keys were handed over in September 2021. In mid-October 2021, the first round of employees moved in. The complex move took place in several stages and involved many additional tasks for all administrative units. The Informatics unit, headed by Alain Bertolotti, migrated all systems and equipment to the more modern and powerful IT environment in the new building. The Infrastructure unit took care of the logistics for the relocation of the offices, training rooms and laboratories. In addition, the temporary building for the Center for Tropical and Travel Medicine was also converted. The Human Resources unit, headed by Iris Haueter, was responsible for the change process and carried out the onboarding for the employees.

New horizons The open working environment promotes interdisciplinary exchange and contributes to improved collaboration between individual departments and units. The office landscape allows flexible working and presents opportunities for interaction as well as retreat areas for concentrated work. Researchers now have access to new and better technologies in the laboratories as well as significantly more space. Swiss TPH employees were able to actively contribute their ideas regarding the use of the building during the construction process as. For example, the cafeteria concept and the various work areas such as project, lounge and quiet zones were created based on their feedback. Mathias Kronig, Administrative Director

Strategic areas Responsible management is a high priority at Swiss TPH. Therefore, the “Tell-Us-System” was introduced, which is an independent reporting system for misconduct and grievances to eliminate conditions that violate legal and moral-ethical regulations. In 2021, working conditions were also improved with the introduction of an additional week of vacation and an increase in paternity leave from two to six weeks. This was a response to the concerns of employees, as revealed by the 2020 employee survey, and strengthens Swiss TPH as an attractive employer.

Organisational changes Mathias Kronig was elected as the new Administrative Director in June 2021. In the months before, he already acted as Administrative Director ad interim. The Finances and Controlling unit is now co-led by Deniz Gör and Stephan Schwarz.

Organigram 2022

Board of Governors

Members from the cantons of Basel-Stadt and Basel-Landschaft, Swiss universities and the private sector Chairman

Andreas Burckhardt

Administration

Administration

Mathias Kronig

Deputy: Iris Haueter & Alain Bertolotti Finances/Controlling

Deniz Gör & Stephan Schwarz

Human Resources

Iris Haueter

Informatics

Alain Bertolotti

Infrastructure

Florian Frenzel

Directorate

Director

Jürg Utzinger

Deputy Director and Department Head

Kaspar Wyss

Department Heads

Julia Bohlius, Sébastien Gagneux, Kaspar Wyss, Daniel Paris, Nicole Probst-Hensch

Administrative Director

Mathias Kronig

Departments

Epidemiology and Public Health

Nicole Probst-Hensch

Deputy: Jakob Zinsstag Biostatistics

Penelope Vounatsou

Chronic Disease Epidemiology

Nicole Probst-Hensch

Disease Modelling

Melissa Penny

Ecosystem Health Sciences

Guéladio Cissé

Environmental Exposures and Health

Martin Röösli

Health Interventions

Christian Lengeler

Household Economics and Health Systems Research

Günther Fink

Human and Animal Health

Jakob Zinsstag

Society, Gender and Health

Sonja Merten

Vector Biology

Pie Müller

Medical Parasitology and Infection Biology

Sébastien Gagneux

Deputy: Till Voss Clinical Immunology

Claudia Daubenberger

Helminth Drug Development

Jennifer Keiser

Malaria Gene Regulation

Till Voss

Malaria Host Interactions

Nicolas Brancucci

Parasite Chemotherapy

Pascal Mäser

Tuberculosis Research Sébastien Gagneux

Communications, Sabina Beatrice-Matter

Internal Audit, Vincent Bodenez

Medical Services, Esther Künzli &

Andreas Neumayr

Project & Grant, Michael Käser

Security, Safety & Health,

Marco Tamborrini

Swiss Centre for International Health

Kaspar Wyss Digital Health Martin Raab

Health Systems Support

Helen Prytherch

Systems Performance and Monitoring

Odile Pham-Tan

Medicine

Daniel Paris

Deputy: Christian Burri Clinical Operations

Elisabeth Reus

Clinical Research

Klaus Reither

Diagnostics

Beatrice Nickel

Medicines Development

Daniel Paris

Medicines Implementation Research

Christian Burri

Education and Training

Julia Bohlius

Deputy: Axel Hoffmann Bachelor-Master-Doctorate

Peter Odermatt

Library and Documentation

Giovanni Casagrande

Professional Postgraduate Training

Karin Gross

Teaching Technology and Didactics

Axel Hoffmann

Organigram valid May 2022 All Swiss TPH staff: www.swisstph.ch/staff